Work

Immunotherapy targeting EBV-expressing lymphoproliferative diseases

Year: 2008

Type: review

Source: Best Practice & Research Clinical Haematology

DOI: 10.1016/j.beha.2008.06.002

Authors: Catherine M. Bollard, Laurence J. Cooper, Helen E. Heslop

Institutions: Houston Methodist, Baylor College of Medicine, Texas Children's Hospital, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Viral-associated cancers and disorders

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Awards: ENHANCING T CELL THERAPY OF CANCER, G348510721, G3825694066, Enhancing the efficacy of CD19-specific cord blood-derived T Cells, Adoptive immunotherapy after umbilical cord blood transplant, SPORE in Lymphoma

OpenAlex ID: W2054292702

FWCI: 0.267

Cites: 72

Cited by: 33

Related to: 10